Additional information
Laboratory | Exult Diagnostics, Dr. Lal PathLabs |
---|
Laboratory | Exult Diagnostics, Dr. Lal PathLabs |
---|
₹ 25000
EX1650 ONCOPRO HEREDITARY CANCER RISK PANEL | |||||||
Specimen: | 10 mL (8 mL min.) whole blood in 1 Lavender Top (EDTA) tube. The ship immediately at 18–22°C. DO NOT REFRIGERATE OR FREEZE. | ||||||
Stability: |
|
||||||
Method: | Next-Generation Sequencing | ||||||
Comment: | |||||||
Report: | Contact us to know the TAT. | ||||||
Usage: | This test is useful for assessing the risk of hereditary cancer. The test covers 98 genes targetting 25 hereditary cancers. The genes selected are based on the NCCN guidelines and peer-reviewed literature. The cancers covered are Breast, Ovarian, Uterine, Stomach, Endocrine Pancreas, Esophagus, Colorectal, Endometrium, Ovarian, Bone, Thyroid, Kidneys, Urinary tract, Lung, Prostate, Central Nervous System, Head & Neck, Liver, Cervix, Exocrine Pancreas, Small Intestine, Blood, Soft Tissue, Skin, Peripheral Nervous system & Endocrine Glands. | ||||||
Doctor Specialty: | Physician, Oncologist | ||||||
Disease: | Cancer | ||||||
Components: | Screens 98 genes: *AIP, *ALK, *APC, *ATM,*BAP1, *BARD1, *BLM, *BMPR1A, *BRCA1, *BRCA2, *BRIP1, *BUB1B, *CDC73, *CDH1, *CDK4, *CDKN1C, *CDKN2A, *CEBPA, *CEP57, *CHEK2, *CYLD, *DDB2, *DICER1, *DIS3L2, *EGFR, *EPCAM ,*ERCC2, *ERCC3, *ERCC4, *ERCC5, *EXT1, *EXT2, *EZH2, *FANCA, *FANCB, *FANCC, *FANCD2, *FANCE, *FANCF, *FANCG, *FANCI, *FANCL, *FANCM, *FH, *FLCN, *GATA2, *GPC3, *HNF1A, *HOXB13, *HRAS, *KIT, *MAX, *MEN1, *MET, *MLH1, *MSH2, *MSH6, *MUTYH, *NBN, *NF1, *NF2, *NSD1, *PALB2, *PHOX2B, *PMS1, *PMS2, *PPM1D, *PRF1, *PRKAR1A, *PTCH1, *PTEN, *RAD51C, *RAD51D, *RB1, *RECQL4, *RET, *RHBDF2, *RUNX1, *SBDS, *SDHAF2, *SDHB, *SDHC, *SDHD, *SLX4, *SMAD4, *SMARCA4, *SMARCB1, *STK11, *SUFU, *TMEM127, *TP53, *TSC1, *TSC2, *VHL, *WT1, *WRN, *XPA, *XPC | ||||||
Courier Charges: | |||||||
Home Collection: | Available (*T&C Apply) | ||||||
Department: | MOLECULAR DIAGNOSTICS | ||||||
Pre Test Information: | A duly filled Oncopro Hereditary Cancer Risk Clinical Information Form is mandatory. |
a division of exult cares pvt. ltd.
Reviews
There are no reviews yet.